The Latest Breaking News from AstraZeneca

Brave schoolboy Max Johnson said the Government should offer vital protection to hundreds of thousands of immuno-compromised people who, like him, could risk being killed by Covid-19

“To see CEO pay rocketing to more than 100 times the average salary is sickening,” say union bosses

AstraZeneca is the IBD Stock Of The Day amid growing enthusiasm for its cancer drug, Enhertu. But AZN stock hit resistance Monday.

New technology involving miniature human organs built in a lab is a step towards better treatments and ending a contentious practice

Pfizer (NYSE:PFE) announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD). The study met two co-primary objectives, associated with immunogenicity responses. Pfizer shares traded in a range of $48.55 to…

BALTIMORE — The tally of wasted COVID-19 vaccine continues to climb at the troubled Emergent BioSolutions plant in East Baltimore and now exceeds a half billion doses, according to findings a congressional panel released Thursday on the manufacturer once central to the U.S. coronavirus pandemic response.

In his first media interview since losing his Senate seat, Zed Seselja said he believed voters had made up their minds about the Morrison government before the election.

With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.

Here's a roundup of top developments in the biotech space over the last 24 hours: